SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-001594
Filing Date
2023-01-09
Accepted
2023-01-09 12:15:13
Documents
12
Period of Report
2023-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea171345-8k_gamidacell.htm   iXBRL 8-K 30140
  Complete submission text file 0001213900-23-001594.txt   203956

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gmda-20230109.xsd EX-101.SCH 3236
3 XBRL LABEL FILE gmda-20230109_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE gmda-20230109_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT ea171345-8k_gamidacell_htm.xml XML 3619
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38716 | Film No.: 23517358
SIC: 2836 Biological Products, (No Diagnostic Substances)